TOKYO —

The pervasive impact of excessive salt consumption on human health extends far beyond its well-established link to hypertension, with mounting scientific evidence pointing to significant disruptions in cognitive function, memory, and emotional well-being. This growing understanding elevates the urgency of finding effective countermeasures against the detrimental effects of high salt intake, a major public health concern worldwide. In a significant step forward, researchers in Japan have identified a promising compound derived from soy, known as LPC70, which demonstrates a remarkable ability to mitigate these adverse consequences, particularly by influencing critical signaling pathways in both the brain and kidneys.

The latest findings, published in the esteemed journal Neurochemistry International on July 1, 2026, build upon earlier research that indicated LPC70’s potential to reduce high blood pressure and cognitive impairments associated with a high-salt diet (HSD) in animal models. The new study delves deeper into the molecular mechanisms, revealing how this soy-derived ingredient actively modulates the body’s intricate prostaglandin (PG) signaling system, a network of chemical messengers crucial for regulating a vast array of physiological processes.

Unraveling the Prostaglandin Puzzle

Prostaglandins, derived from the fatty acid arachidonic acid (AA), function as localized hormones, orchestrating vital bodily functions. Within the cardiovascular system, they play a pivotal role in blood pressure regulation by influencing the dilation and constriction of blood vessels. Their impact on the brain, however, is considerably more complex. Depending on the specific receptors they engage, prostaglandins can either promote neuroprotection or contribute to harmful processes that can impair memory, cognitive abilities, and emotional regulation.

LPC70, a specific form of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine (LPC)—exceeding 70% of its phospholipids—has previously shown efficacy in alleviating salt-induced hypertension and cognitive deficits in mice. However, the precise biochemical pathways responsible for these benefits remained largely unelucidated until this recent investigation.

A Collaborative Endeavor for Deeper Understanding

A dedicated research team, spearheaded by Professor Akihiro Mouri and Dr. Hisayoshi Kubota from the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals & Devices at Fujita Health University Graduate School of Medical Science, and the International Center for Brain Science (ICBS) at Fujita Health University, alongside Dr. Kazuhiro Kagotani from Tsuji Oil Mills Co., Ltd. and the Tsuji Health and Beauty Science Laboratory at Mie University, embarked on a mission to unravel LPC70’s influence on prostaglandin signaling.

Dr. Kubota, the study’s lead author, meticulously conducted experiments involving blood pressure monitoring, behavioral assessments, and molecular analyses of prostaglandin-associated activities. His detailed work provided critical insights into how LPC70 exerts its protective effects across the organs implicated in salt-related cardiovascular and cognitive disorders. This collaborative research project, originating from a partnership with Tsuji Oil Mills Co., Ltd., a company specializing in naturally derived food ingredients, underscored the potential of functional food components in addressing prevalent health challenges.

High Salt’s Toll: Beyond Blood Pressure

The study began by replicating known outcomes: mice fed a high-salt diet exhibited significantly elevated blood pressure. However, the ramifications of excessive sodium intake extended beyond the cardiovascular system. The HSD-fed mice displayed a marked decrease in social interaction and demonstrated difficulties in recognizing previously encountered objects, clear indicators of impaired memory function. Notably, these cognitive and social deficits did not translate into widespread behavioral impairments, such as significant changes in general motor activity or anxiety levels. This selective disruption highlighted how excessive salt disproportionately affects more complex cognitive and social functions.

LPC70 Intervention: Restoring Balance

The introduction of LPC70 into the diets of these mice yielded encouraging results. The compound demonstrably reduced the severity of the observed negative effects. Blood pressure levels improved, and the mice showed enhanced performance in tests designed to assess social interaction and object recognition memory. These improvements spurred the researchers to investigate the underlying molecular changes within the animals’ kidneys and brains.

Differential Protective Mechanisms in Kidneys and Brain

The research team observed distinct molecular responses in the kidneys and the brain. In the kidneys, a high-salt diet led to an increased expression of cyclooxygenase-2 (COX-2) and the prostaglandin E2 (PGE2) receptor EP3. Both of these components are implicated in the development of salt-sensitive hypertension. LPC70 effectively counteracted these salt-induced elevations, suggesting that the compound helps normalize kidney signaling pathways that are crucial for maintaining healthy blood pressure regulation.

Conversely, in the prefrontal cortex—a brain region vital for executive functions, memory, and social behavior—the effects of excess salt were different. High salt consumption reduced the expression of the prostaglandin D2 (PGD2) receptor DP1. This receptor is known to mediate protective and anti-inflammatory signaling within the brain. LPC70 treatment successfully restored the expression of DP1, while importantly leaving unaffected the expression of DP2, another PGD2 receptor linked to potentially detrimental effects on neural cells. This nuanced effect underscores LPC70’s ability to selectively modulate prostaglandin signaling, favoring pathways that confer neuroprotection and potentially explaining the observed improvements in memory and social behavior.

A Surprising Shift in Arachidonic Acid Metabolism

Adding another layer of complexity, the researchers uncovered an unexpected alteration in the availability and utilization of arachidonic acid, the precursor for prostaglandin synthesis. Mice consuming excess salt exhibited lower levels of circulating arachidonic acid. However, upon administration of LPC70, the levels of prostaglandins derived from this fatty acid, including PGE2 and PGD2, actually increased. This seemingly paradoxical observation suggests that LPC70 may enhance the body’s efficiency in utilizing the available arachidonic acid to produce essential prostaglandins, particularly under the stress of a high-salt diet.

Coordinated Action for Enhanced Health

Collectively, these findings illustrate a sophisticated and organ-specific response to LPC70 intervention. In the kidneys, the compound appears to dampen signaling pathways that contribute to hypertension. In the brain, it actively promotes signaling mechanisms associated with neuroprotection and anti-inflammation. This suggests that LPC70’s therapeutic effects are finely tuned, dependent on both the specific organ and the particular prostaglandin receptors being modulated.

The Future of Functional Foods in Salt Reduction Strategies

The implications of this research are substantial, pointing towards LPC70’s potential to serve as a valuable functional food ingredient in mitigating the adverse health consequences of excessive salt intake. Its demonstrated ability to improve blood pressure and cognitive function in animal models offers a compelling avenue for supporting cardiovascular and brain health, particularly for populations with high dietary salt consumption.

Professor Mouri emphasized the significance of these findings, stating, "Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally." The research provides a clearer understanding of how a soy-derived compound can influence the body’s response to excess salt, paving the way for novel nutritional strategies to safeguard long-term health.

Context and Broader Impact

The global prevalence of high salt consumption is staggering. The World Health Organization (WHO) recommends that adults consume less than 5 grams of salt (equivalent to 2 grams of sodium) per day. However, current estimates indicate that average salt intake in many parts of the world far exceeds this recommendation, contributing significantly to the global burden of cardiovascular diseases, which remain the leading cause of death worldwide. For instance, in the United States, the average daily sodium intake is estimated to be over 3,400 milligrams, significantly higher than the recommended limit of 2,300 milligrams per day. This widespread overconsumption creates a substantial public health challenge, driving the need for innovative dietary solutions.

The timeline of this research highlights a progressive understanding of salt’s impact. Initial concerns primarily focused on blood pressure. However, as neuroscientific research advanced, the intricate connections between diet and brain health became clearer. This study, initiated as a collaborative project with Tsuji Oil Mills Co., Ltd., aligns with a growing trend in nutritional science to explore naturally derived compounds for their therapeutic potential. The research was officially released online on May 14, 2026, and subsequently published in Neurochemistry International in July 2026, marking a significant milestone in the scientific community’s understanding of dietary interventions.

Official Statements and Potential Future Directions

While specific reactions from independent health organizations were not immediately available following the publication, the scientific community is likely to view these findings with considerable interest. Experts in public health and nutrition will undoubtedly be looking towards the translation of these promising animal study results into human clinical trials. Professor Mouri’s concluding remarks underscore this forward-looking perspective, suggesting that this research is not an endpoint but a crucial step towards developing evidence-based dietary recommendations and interventions.

The implications for the food industry are also noteworthy. As consumers become increasingly health-conscious, the demand for functional foods that offer specific health benefits is on the rise. LPC70, if proven effective in humans, could become a valuable ingredient in a range of products designed to help individuals manage their salt intake and mitigate its negative health consequences. This could include processed foods, snacks, and even condiments, offering a proactive approach to health maintenance.

However, it is crucial to reiterate that these findings are derived from animal experiments. The leap from mice to humans is not always direct, and further rigorous clinical studies are essential to validate these effects in human populations. Such studies would need to assess not only the efficacy of LPC70 in reducing blood pressure and improving cognitive function but also its safety profile and optimal dosage for human consumption.

Funding and Support for Advancing Research

The comprehensive nature of this research was facilitated by significant financial and institutional support. Grants from the Japan Society for the Promotion of Science (JSPS) under various grant numbers (20K07931, 22K07606, 22K11891, and 23H02843) provided foundational funding. Additional support was channeled through the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe) as part of Japan’s Peak Research Universities (J-PEAKS) Program (JPJS00420240019) and the Japan Science and Technology Agency FOREST Program (JPMJFR215H).

Crucially, Tsuji Oil Mills Co., Ltd. provided direct financial backing for the research, underscoring the industry’s commitment to investigating novel health-promoting ingredients. Further support emanated from the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation, collectively underscoring a broad-based commitment to advancing scientific understanding in this critical area of health. This multi-faceted support structure highlights the collaborative ecosystem necessary to tackle complex health challenges through rigorous scientific inquiry.